Pradeep Vaitla

Dr. Pradeep Vaitla

Auto-generated profile, based on publicly available information

Dr. Pradeep Vaitla


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Diseases
Verified
Journal Article
Open access
PDF file
PAPrakrati C. Acharya
Prakrati C. Acharya
CAChirag Acharya
Chirag Acharya
CTCharat Thongprayoon
Charat Thongprayoon
PHPanupong Hansrivijit
Panupong Hansrivijit
SKSwetha Rani Kanduri
Swetha Rani Kanduri
Wisit CheungpasitpornWisit Cheungpasitporn
Wisit Cheungpasitporn
Very-low-carbohydrate diets or ketogenic diets are frequently used for weight loss in adults and as a therapy for epilepsy in children. The incidence and characteristics of kidney stones in patients on ketogenic diets are not well studied. Methods: A systematic literature search was performed, using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from the databases’ inception through April 2020. Observational studies or clinical trials that provide data on the incidence and/or types of kidney stones in patients on ketogenic diets were included. We applied a random-effects model to estimate the incidence of kidney stones. Results: A total of 36 studies with 2795 patients on ketogenic diets were enrolled. The estimated pooled incidence of kidney stones was 5.9% (95% CI, 4.6–7.6%, I2 = 47%) in patients on ketogenic diets at a mean follow-up time of 3.7 +/− 2.9 years. Subgroup analyses demonstrated the estimated pooled incidence of kidney stones of 5.8% (95% CI, 4.4–7.5%, I2 = 49%) in children and 7.9% (95% CI, 2.8–20.1%, I2 = 29%) in adults, respectively. Within reported studies, 48.7% (95% CI, 33.2–64.6%) of kidney stones were uric stones, 36.5% (95% CI, 10.6–73.6%) were calcium-based (CaOx/CaP) stones, and 27.8% (95% CI, 12.1–51.9%) were mixed uric acid and calcium-based stones, respectively. Conclusions: The estimated incidence of kidney stones in patients on ketogenic diets is 5.9%. Its incidence is approximately 5.8% in children and 7.9% in adults. Uric acid stones are the most prevalent kidney stones in patients on ketogenic diets followed by calcium-based stones. These findings may impact the prevention and clinical management of kidney stones in patients on ketogenic diets.

1 August 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
TSTariq Shafi
Tariq Shafi
XZXiaoqian Zhu
Xiaoqian Zhu
SLSeth T. Lirette
Seth T. Lirette
ARAndrew D. Rule
Andrew D. Rule
TMThomas Mosley
Thomas Mosley
JBJaved Butler
Javed Butler
Population-level differences between estimated and measured glomerular filtration rates (eGFRs and mGFRs) are well recognized. This study quantifies the magnitude of less well-known individual-leve... Visual Quantifying Individual-Level Inaccuracy in GFR Estimation. Population-level differences between estimated and measured glomerular filtration rates (eGFRs and mGFRs) are well recogni... Background Although the population-level differences between estimated glomerular filtration rate (eGFR) and measured glomerular filtration rate (mGFR) are well recognized, the magnitude and potent...

Verified
Journal Article
Open access
PDF file
CTCharat Thongprayoon
Charat Thongprayoon
PVPradeep Vaitla
Pradeep Vaitla
ICIasmina M. Craici
Iasmina M. Craici
NLNapat Leeaphorn
Napat Leeaphorn
PHPanupong Hansrivijit
Panupong Hansrivijit
Wisit CheungpasitpornWisit Cheungpasitporn
Wisit Cheungpasitporn
Patient monitoring after kidney transplantation (KT) for early detection of allograft rejection remains key in preventing allograft loss. Serum creatinine has poor predictive value to detect ongoing active rejection as its increase is not sensitive, nor specific for acute renal allograft rejection. Diagnosis of acute rejection requires allograft biopsy and histological assessment, which can be logistically challenging in some cases and carries inherent risk for complications related to procedure. Donor-derived cell-free DNA (dd-cfDNA), DNA of donor origin in the blood of KT recipient arising from cells undergoing injury and death, has been examined as a potential surrogate marker for allograft rejection. A rise in dd-cfDNA levels precedes changes in serum creatinine allows early detections and use as a screening tool for allograft rejection. In addition, when used in conjunction with donor-specific antibodies (DSA), it increases the pre-biopsy probability of antibody-mediated rejection (ABMR) aiding the decision-making process. Advancements in noninvasive biomarker assays such as dd-cfDNA may offer the opportunity to improve and expand the spectrum of available diagnostic tools to monitor and detect risk for rejection and positively impact outcomes for KT recipients. In this this article, we discussed the evolution of dd-cfDNA assays and recent evidence of assessment of allograft rejection and injury status of KT by the use of dd-cfDNA.

19 June 2020 in Medicina
Verified
Journal Article
Open access
PDF file
KKKarthik Kovvuru
Karthik Kovvuru
SKSwetha Rani Kanduri
Swetha Rani Kanduri
PVPradeep Vaitla
Pradeep Vaitla
RMRachana Marathi
Rachana Marathi
SGShiva Gosi
Shiva Gosi
VGVishnu Garla
Vishnu Garla
Bone and mineral disorders are common after organ transplantation. Osteoporosis post transplantation is associated with increased morbidity and mortality. Pathogenesis of bone disorders in this particular sub set of the population is complicated by multiple co-existing factors like preexisting bone disease, Vitamin D deficiency and parathyroid dysfunction. Risk factors include post-transplant immobilization, steroid usage, diabetes mellitus, low body mass index, older age, female sex, smoking, alcohol consumption and a sedentary lifestyle. Immunosuppressive medications post-transplant have a negative impact on outcomes, and further aggravate osteoporotic risk. Management is complex and challenging due to the sub-optimal sensitivity and specificity of non-invasive diagnostic tests, and the underutilization of bone biopsy. In this review, we summarize the prevalence, pathophysiology, diagnostic tests and management of osteoporosis in solid organ and hematopoietic stem cell transplant recipients.

1 December 2020 in Journal of Critical Care
Verified
Journal Article
Closed access
PHPanupong Hansrivijit
Panupong Hansrivijit
KYKeerthi Yarlagadda
Keerthi Yarlagadda
MPMax M. Puthenpura
Max M. Puthenpura
NGNasrollah Ghahramani
Nasrollah Ghahramani
CTCharat Thongprayoon
Charat Thongprayoon
WCWisit Cheungpasitporn
Wisit Cheungpasitporn

Verified
Journal Article
Open access
PDF file
Wisit CheungpasitpornWisit Cheungpasitporn
Wisit Cheungpasitporn
CTCharat Thongprayoon
Charat Thongprayoon
PVPradeep K Vaitla
Pradeep K Vaitla
ACApi Chewcharat
Api Chewcharat
PHPanupong Hansrivijit
Panupong Hansrivijit
NLNapat Leeaphorn
Napat Leeaphorn
Background: This study aimed to assess the association between the percentage of glomerulosclerosis (GS) in procurement allograft biopsies from high-risk deceased donor and graft outcomes in kidney transplant recipients. Methods: The UNOS database was used to identify deceased-donor kidneys with a kidney donor profile index (KDPI) score > 85% from 2005 to 2014. Deceased donor kidneys were categorized based on the percentage of GS: 0–10%, 11–20%, >20% and no biopsy performed. The outcome included death-censored graft survival, patient survival, rate of delayed graft function, and 1-year acute rejection. Results: Of 22,006 kidneys, 91.2% were biopsied showing 0–10% GS (58.0%), 11–20% GS (13.5%), >20% GS (19.7%); 8.8% were not biopsied. The rate of kidney discard was 48.5%; 33.6% in 0–10% GS, 68.9% in 11–20% GS, and 77.4% in >20% GS. 49.8% of kidneys were discarded in those that were not biopsied. Death-censored graft survival at 5 years was 75.8% for 0–10% GS, 70.9% for >10% GS, and 74.8% for the no biopsy group. Among kidneys with >10% GS, there was no significant difference in death-censored graft survival between 11–20% GS and >20% GS. Recipients with >10% GS had an increased risk of graft failure (HR = 1.27, p < 0.001), compared with 0–10% GS. There was no significant difference in patient survival, acute rejection at 1-year, and delayed graft function between 0% and 10% GS and >10% GS. Conclusion: In >85% KDPI kidneys, our study suggested that discard rates increased with higher percentages of GS, and GS >10% is an independent prognostic factor for graft failure. Due to organ shortage, future studies are needed to identify strategies to use these marginal kidneys safely and improve outcomes.